| Literature DB >> 27610572 |
Meromit Singer1, Chao Wang2, Le Cong1, Nemanja D Marjanovic3, Monika S Kowalczyk1, Huiyuan Zhang2, Jackson Nyman1, Kaori Sakuishi2, Sema Kurtulus2, David Gennert1, Junrong Xia2, John Y H Kwon1, James Nevin2, Rebecca H Herbst1, Itai Yanai4, Orit Rozenblatt-Rosen1, Vijay K Kuchroo5, Aviv Regev6, Ana C Anderson7.
Abstract
Reversing the dysfunctional T cell state that arises in cancer and chronic viral infections is the focus of therapeutic interventions; however, current therapies are effective in only some patients and some tumor types. To gain a deeper molecular understanding of the dysfunctional T cell state, we analyzed population and single-cell RNA profiles of CD8(+) tumor-infiltrating lymphocytes (TILs) and used genetic perturbations to identify a distinct gene module for T cell dysfunction that can be uncoupled from T cell activation. This distinct dysfunction module is downstream of intracellular metallothioneins that regulate zinc metabolism and can be identified at single-cell resolution. We further identify Gata-3, a zinc-finger transcription factor in the dysfunctional module, as a regulator of dysfunction, and we use CRISPR-Cas9 genome editing to show that it drives a dysfunctional phenotype in CD8(+) TILs. Our results open novel avenues for targeting dysfunctional T cell states while leaving activation programs intact.Entities:
Keywords: CD8; CRISPR/Cas9; Gata-3; T cell; TILs; cancer; dysfunction; exhaustion; metallothioneins; single-cell; tumor; zinc
Mesh:
Substances:
Year: 2016 PMID: 27610572 PMCID: PMC5019125 DOI: 10.1016/j.cell.2016.08.052
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582